Generic Version Of Viagra To Launch In 2017

By: Benzinga
Pfizer (NYSE: PFE ) has come to a settlement with Israel's Teva Pharmaceutical Industries (NYSE: TEVA ), that will allow Teva to to launch a generic version of the anti-impotency drug Viagra in late 2017. While most of the agreement's terms remain confidential, Pfizer says Teva will pay
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.